Steven Cohen Cytokinetics Inc Transaction History

Point72 Asset Management, L.P.

$42.2 Billion
Q4 2024

A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Cytokinetics Inc stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 169,913 shares of CYTK stock, worth $8.69 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

169,913

Previous 464,010 63.38%

Holding current value

$8.69 Million

Previous $24.5 Million 67.38%

% of portfolio

0.02%

Previous 0.07%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$46.36 - $58.62 $13.6 Million - $17.2 Million	-294,097 Reduced 63.38%	169,913 $7.99 Million
Q3 2024 Nov 14, 2024	BUY	$51.22 - $60.16 $4.57 Million - $5.36 Million	89,162 Added 23.79%	464,010 $24.5 Million
Q2 2024 Aug 14, 2024	BUY	$47.86 - $75.05 $485,252 - $760,931	10,139 Added 2.78%	374,848 $20.3 Million
Q1 2024 May 15, 2024	BUY	$63.75 - $108.06 $13.2 Million - $22.4 Million	207,609 Added 132.15%	364,709 $25.6 Million
Q4 2023 Feb 14, 2024	BUY	$26.88 - $83.49 $4.22 Million - $13.1 Million	157,100 New	157,100 $13.1 Million
Q2 2023 Aug 14, 2023	BUY	$32.62 - $40.75 $5.23 Million - $6.54 Million	160,400 New	160,400 $5.23 Million
Q1 2023 May 15, 2023	SELL	$33.36 - $45.71 $9.06 Million - $12.4 Million	-271,500 Closed	0 $0
Q4 2022 Feb 14, 2023	BUY	$35.77 - $51.11 $8.57 Million - $12.2 Million	239,500 Added 748.44%	271,500 $12.4 Million
Q3 2022 Nov 14, 2022	BUY	$38.54 - $54.52 $476,624 - $674,248	12,367 Added 62.99%	32,000 $1.55 Million
Q2 2022 Aug 15, 2022	SELL	$33.93 - $48.92 $54.4 Million - $78.4 Million	-1,602,967 Reduced 98.79%	19,633 $771,000
Q1 2022 May 16, 2022	BUY	$29.74 - $46.0 $21.9 Million - $33.9 Million	737,146 Added 83.25%	1,622,600 $59.7 Million
Q4 2021 Feb 14, 2022	SELL	$34.35 - $46.38 $4.25 Million - $5.74 Million	-123,846 Reduced 12.27%	885,454 $40.4 Million
Q3 2021 Nov 15, 2021	BUY	$18.54 - $35.74 $12.6 Million - $24.4 Million	681,800 Added 208.18%	1,009,300 $36.1 Million
Q2 2021 Aug 16, 2021	SELL	$19.79 - $26.99 $932,109 - $1.27 Million	-47,100 Reduced 12.57%	327,500 $6.48 Million
Q1 2021 May 17, 2021	SELL	$18.57 - $25.68 $14.7 Million - $20.3 Million	-791,694 Reduced 67.88%	374,600 $8.71 Million
Q4 2020 Feb 16, 2021	SELL	$15.26 - $28.61 $6.72 Million - $12.6 Million	-440,056 Reduced 27.39%	1,166,294 $24.2 Million
Q3 2020 Nov 16, 2020	BUY	$20.58 - $28.96 $26.3 Million - $37 Million	1,278,073 Added 389.33%	1,606,350 $34.8 Million
Q2 2020 Aug 14, 2020	SELL	$11.15 - $24.64 $5.16 Million - $11.4 Million	-462,923 Reduced 58.51%	328,277 $7.74 Million
Q1 2020 May 15, 2020	SELL	$8.75 - $16.3 $19.6 Million - $36.5 Million	-2,237,551 Reduced 73.88%	791,200 $9.33 Million
Q4 2019 Feb 14, 2020	BUY	$7.95 - $11.84 $20.6 Million - $30.7 Million	2,594,651 Added 597.71%	3,028,751 $32.1 Million
Q3 2019 Nov 15, 2019	SELL	$10.82 - $14.25 $1.87 Million - $2.46 Million	-172,900 Reduced 28.48%	434,100 $4.94 Million
Q2 2019 Aug 14, 2019	BUY	$7.95 - $11.25 $4.83 Million - $6.83 Million	607,000 New	607,000 $6.83 Million

Others Institutions Holding CYTK

# of Institutions

396

Shares Held

122M

Call Options Held

3.46M

Put Options Held

1.86M

View Full List

About CYTOKINETICS INC

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.81B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

More about CYTK

Track Steven Cohen's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.

Account